These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 31871226)

  • 21. Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8
    Korenkov D; Nguyen THO; Isakova-Sivak I; Smolonogina T; Brown LE; Kedzierska K; Rudenko L
    Hum Vaccin Immunother; 2018 Apr; 14(4):941-946. PubMed ID: 29252117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine.
    Korenkov D; Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2018 Nov; 17(11):977-987. PubMed ID: 30365908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
    Pandey A; Singh N; Vemula SV; Couëtil L; Katz JM; Donis R; Sambhara S; Mittal SK
    PLoS One; 2012; 7(3):e33428. PubMed ID: 22432020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation.
    Parmigiani A; Alcaide ML; Freguja R; Pallikkuth S; Frasca D; Fischl MA; Pahwa S
    PLoS One; 2013; 8(11):e79816. PubMed ID: 24236161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heterosubtypic immunity to influenza A viruses: epidemiological data, involvement of different immunological factors, vaccination].
    Naĭkhin AN
    Vopr Virusol; 2012; 57(3):4-9. PubMed ID: 22905419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.
    Herrera MT; Gonzalez Y; Juárez E; Hernández-Sánchez F; Carranza C; Sarabia C; Guzman-Beltran S; Manjarrez ME; Muñoz-Torrico M; Garcia-Garcia L; Sada E; Torres M
    BMC Infect Dis; 2013 Nov; 13():544. PubMed ID: 24238117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced CD103 Expression and Reduced Frequencies of Virus-Specific CD8
    Surman SL; Jones BG; Woodland DL; Hurwitz JL
    Viral Immunol; 2017 Dec; 30(10):737-743. PubMed ID: 29130830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.
    Combadière B; Vogt A; Mahé B; Costagliola D; Hadam S; Bonduelle O; Sterry W; Staszewski S; Schaefer H; van der Werf S; Katlama C; Autran B; Blume-Peytavi U
    PLoS One; 2010 May; 5(5):e10818. PubMed ID: 20520820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model.
    Carreño JM; Strohmeier S; Kirkpatrick Roubidoux E; Hai R; Palese P; Krammer F
    mBio; 2020 Dec; 11(6):. PubMed ID: 33323511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.
    Aljurayyan A; Puksuriwong S; Ahmed M; Sharma R; Krishnan M; Sood S; Davies K; Rajashekar D; Leong S; McNamara PS; Gordon S; Zhang Q
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines.
    De Groot AS; McClaine E; Moise L; Martin W
    Hum Vaccin; 2010 Feb; 6(2):161-63. PubMed ID: 20431339
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune responses after live attenuated influenza vaccination.
    Mohn KG; Smith I; Sjursen H; Cox RJ
    Hum Vaccin Immunother; 2018 Mar; 14(3):571-578. PubMed ID: 28933664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aging and influenza vaccine-induced immunity.
    Dugan HL; Henry C; Wilson PC
    Cell Immunol; 2020 Feb; 348():103998. PubMed ID: 31733824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio.
    Strindhall J; Ernerudh J; Mörner A; Waalen K; Löfgren S; Matussek A; Bengner M
    Infect Dis (Lond); 2016; 48(6):436-42. PubMed ID: 27030916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.
    Bragstad K; Martel CJ; Thomsen JS; Jensen KL; Nielsen LP; Aasted B; Fomsgaard A
    Influenza Other Respir Viruses; 2011 Jan; 5(1):13-23. PubMed ID: 21138536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal priming with immunobiotic lactobacilli improves the adaptive immune response against influenza virus.
    Tonetti FR; Islam MA; Vizoso-Pinto MG; Takahashi H; Kitazawa H; Villena J
    Int Immunopharmacol; 2020 Jan; 78():106115. PubMed ID: 31841753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
    Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
    PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Killer T cells in influenza.
    Stambas J; Guillonneau C; Kedzierska K; Mintern JD; Doherty PC; La Gruta NL
    Pharmacol Ther; 2008 Nov; 120(2):186-96. PubMed ID: 18801385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines.
    Altenburg AF; van Trierum SE; de Bruin E; de Meulder D; van de Sandt CE; van der Klis FRM; Fouchier RAM; Koopmans MPG; Rimmelzwaan GF; de Vries RD
    Sci Rep; 2018 Apr; 8(1):6474. PubMed ID: 29692427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.